Trastuzumab Suspended Phase 2 Trials for Colorectal Cancers Treatment

Indications	Status	Purpose	Phase
DBCOND0063246 (Colorectal Cancers)	Suspended	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02291289	A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)	Cobimetinib (DB05239) Bevacizumab (DB00112) Trastuzumab (DB00072) Pertuzumab (DB06366) Fluorouracil (DB00544) Atezolizumab (DB11595) Vemurafenib (DB08881) Cetuximab (DB00002)